These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 24856280

  • 1. A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy.
    Mallia MB, Subramanian S, Mathur A, Sarma HD, Banerjee S.
    Nucl Med Biol; 2014 Aug; 41(7):600-10. PubMed ID: 24856280
    [Abstract] [Full Text] [Related]

  • 2. On the structural modification of 2-nitroimidazole-(99m)Tc(CO)(3) complex, a hypoxia marker, for improving in vivo pharmacokinetics.
    Mallia MB, Kumar C, Mathur A, Sarma HD, Banerjee S.
    Nucl Med Biol; 2012 Nov; 39(8):1236-42. PubMed ID: 22938843
    [Abstract] [Full Text] [Related]

  • 3. Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole-dipicolylamine-(99m)Tc(CO)3 complex for detecting tumor hypoxia.
    Mallia MB, Mittal S, Sarma HD, Banerjee S.
    Bioorg Med Chem Lett; 2016 Jan 01; 26(1):46-50. PubMed ID: 26615889
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, in vitro and in vivo characterization of novel 99mTc-'4+1'-labeled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
    Giglio J, Fernández S, Pietzsch HJ, Dematteis S, Moreno M, Pacheco JP, Cerecetto H, Rey A.
    Nucl Med Biol; 2012 Jul 01; 39(5):679-86. PubMed ID: 22534030
    [Abstract] [Full Text] [Related]

  • 5. A (99m)Tc-labeled misonidazole analogue: step toward a (99m)Tc-alternative to [18F]fluromisonidazole for detecting tumor hypoxia.
    Mallia MB, Mathur A, Sarma HD, Banerjee S.
    Cancer Biother Radiopharm; 2015 Mar 01; 30(2):79-86. PubMed ID: 25569675
    [Abstract] [Full Text] [Related]

  • 6. ⁹⁹mTc/Re complexes bearing bisnitroimidazole or mononitroimidazole as potential bioreductive markers for tumor: synthesis, physicochemical characterization and biological evaluation.
    Mei L, Wang Y, Chu T.
    Eur J Med Chem; 2012 Dec 01; 58():50-63. PubMed ID: 23088932
    [Abstract] [Full Text] [Related]

  • 7. A thiourea-bridged 99mTc(CO)3-dipicolylamine-2-nitroimidazole complex for targeting tumor hypoxia: Utilizing metabolizable thiourea-bridge to improve pharmacokinetics.
    Mittal S, Kumar C, Jha L, Mallia MB.
    Drug Dev Res; 2024 Sep 01; 85(6):e22258. PubMed ID: 39253992
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
    Giglio J, Dematteis S, Fernández S, Cerecetto H, Rey A.
    J Labelled Comp Radiopharm; 2014 May 30; 57(6):403-9. PubMed ID: 24692093
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
    Su H, Chu T.
    Bioorg Med Chem Lett; 2022 Mar 15; 60():128583. PubMed ID: 35085720
    [Abstract] [Full Text] [Related]

  • 10. Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.
    Li Z, Lin X, Zhang J, Wang X, Jin Z, Zhang W, Zhang Y.
    Nucl Med Biol; 2016 Feb 15; 43(2):165-70. PubMed ID: 26872441
    [Abstract] [Full Text] [Related]

  • 11. On the isolation and evaluation of a novel unsubstituted 5-nitroimidazole derivative as an agent to target tumor hypoxia.
    Mallia MB, Subramanian S, Mathur A, Sarma HD, Venkatesh M, Banerjee S.
    Bioorg Med Chem Lett; 2008 Oct 01; 18(19):5233-7. PubMed ID: 18774708
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
    Zhang Q, Huang H, Chu T.
    J Labelled Comp Radiopharm; 2016 Jan 01; 59(1):14-23. PubMed ID: 26690916
    [Abstract] [Full Text] [Related]

  • 13. Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.
    Huang H, Zhou H, Li Z, Wang X, Chu T.
    Bioorg Med Chem Lett; 2012 Jan 01; 22(1):172-7. PubMed ID: 22153341
    [Abstract] [Full Text] [Related]

  • 14. Technetium glucose complexes as potential cancer imaging agents.
    Dapueto R, Aguiar RB, Moreno M, Machado CM, Marques FL, Gambini JP, Chammas R, Cabral P, Porcal W.
    Bioorg Med Chem Lett; 2015 Oct 01; 25(19):4254-9. PubMed ID: 26318991
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, in vitro and in vivo characterization of two novel 68Ga-labelled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
    Fernández S, Dematteis S, Giglio J, Cerecetto H, Rey A.
    Nucl Med Biol; 2013 Feb 01; 40(2):273-9. PubMed ID: 23218939
    [Abstract] [Full Text] [Related]

  • 16. In vivo click reaction between Tc-99m-labeled azadibenzocyclooctyne-MAMA and 2-nitroimidazole-azide for tumor hypoxia targeting.
    Sun W, Chu T.
    Bioorg Med Chem Lett; 2015 Oct 15; 25(20):4453-6. PubMed ID: 26358160
    [Abstract] [Full Text] [Related]

  • 17. Improving tumor/muscle and tumor/blood ratios of 99mTc-labeled nitroimidazole propylene amine oxime (PnAO) complexes with ethylene glycol linkers.
    Li S, Chu T.
    Bioorg Med Chem Lett; 2023 Feb 15; 82():129154. PubMed ID: 36736496
    [Abstract] [Full Text] [Related]

  • 18. Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO.
    Dos Santos SN, Wuest M, Jans HS, Woodfield J, Nario AP, Krys D, Dufour J, Glubrecht D, Bergman C, Bernardes ES, Wuest F.
    Nucl Med Biol; 2023 Feb 15; 124-125():108383. PubMed ID: 37651917
    [Abstract] [Full Text] [Related]

  • 19. Preparation and evaluation of a ⁹⁹mTcN-PNP complex of sanazole analogue for detecting tumor hypoxia.
    Mathur A, Mallia MB, Banerjee S, Sarma HD, Pillai MR.
    Bioorg Med Chem Lett; 2013 Mar 01; 23(5):1394-7. PubMed ID: 23375795
    [Abstract] [Full Text] [Related]

  • 20. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.
    Mukherjee A, Kothari K, Tóth G, Szemenyei E, Sarma HD, Környei J, Venkatesh M.
    Nucl Med Biol; 2006 Jul 01; 33(5):635-43. PubMed ID: 16843838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.